---
figid: PMC8558790__10.1177_20406207211053120-fig1
figtitle: Integration of cell therapies and bispecific antibodies into the treatment
  pathway of relapsed diffuse large B-cell lymphoma
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Drosophila melanogaster
pmcid: PMC8558790
filename: 10.1177_20406207211053120-fig1.jpg
figlink: /pmc/articles/PMC8558790/figure/fig1-20406207211053120/
number: F1
caption: Pathway for relapsed/refractory DLBCL.ASCT, autologous stem cell transplantation;
  CAR-T, chimeric antigen receptors-T cells; CR, complete response; CT, cell transplantation;
  DLBCL, diffuse large B-cell lymphoma; PET, positron emmission tomography; R-B-pola,
  rituximab, Bendamustine, polatuzumab vedotin; R-DHAP, rituximab, dexamethasone,
  cytarabine, cisplatin; R-ICE, rituximab, ifosfamide, carboplatin, etoposide; VGPR,
  very good partial response.
papertitle: Integration of cell therapies and bispecific antibodies into the treatment
  pathway of relapsed diffuse large B-cell lymphoma.
reftext: Alexandros Rampotas, et al. Ther Adv Hematol. 2021;12:20406207211053120.
year: '2021'
doi: 10.1177/20406207211053120
journal_title: Therapeutic Advances in Hematology
journal_nlm_ta: Ther Adv Hematol
publisher_name: SAGE Publications
keywords: ''
automl_pathway: 0.5959956
figid_alias: PMC8558790__F1
figtype: Figure
redirect_from: /figures/PMC8558790__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8558790__10.1177_20406207211053120-fig1.html
  '@type': Dataset
  description: Pathway for relapsed/refractory DLBCL.ASCT, autologous stem cell transplantation;
    CAR-T, chimeric antigen receptors-T cells; CR, complete response; CT, cell transplantation;
    DLBCL, diffuse large B-cell lymphoma; PET, positron emmission tomography; R-B-pola,
    rituximab, Bendamustine, polatuzumab vedotin; R-DHAP, rituximab, dexamethasone,
    cytarabine, cisplatin; R-ICE, rituximab, ifosfamide, carboplatin, etoposide; VGPR,
    very good partial response.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - fit
  - Aldh-III
  - CycE
  - cyc
  - Orai
  - ct
  - CR
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - CarT
  - if
---
